News – Page 489 – Endpoints News

Granfluencers and boomfluencers: Is the hipster oldster social media trend moving to pharma?

3 years ago

How do you put a positive spin on ugly data? AC Immune gives it a shot in the wake of the latest crenezumab flop

3 years ago

FDA greenlights Marius' oral hypogonadism pill; VBL Therapeutics makes cuts to its workforce

3 years ago

Who's afraid of the FTC? CSL gets its regulatory ducks lined up for $11.7B M&A deal

3 years ago

Ouch: Eliem’s pain drug fails second PhII trial, gets scrapped

3 years ago

CEO of Danish immunotherapy startup hits the exit in the latest C-suite shakeup

3 years ago

After FDA requests a new trial, Allarity drops a cancer drug from solo development

3 years ago

BeiGene co-founder and ex-Viela Bio BD leader snag $200M for age-related biotech, with ARCH jumping in

3 years ago

Roche wins an edge in the hypercompetitive race for PD-(L)1 market share

3 years ago

With some neuro targets in mind, AbbVie gets Sosei's drug discovery engine churning again

3 years ago

French biotech armed with Series A looks to build out manufacturing facility for plant-based protein tech

3 years ago

An MIT professor's rare disease quest ripples throughout biotech

3 years ago

New biotech from Alexis Borisy will test Merck KGaA, Blueprint cancer drug combo in bid to fulfill Gleevec promise

3 years ago

Little biotech developing Genentech castoff drug hits hurdle in glioblastoma platform trial

3 years ago

Axcella flunks long Covid PhII primary goal — but plots a path into PhIII

3 years ago

Under pressure from advocates, ViiV strikes a deal to make its long-acting HIV injectable more accessible

3 years ago

Biogen's new SMA awareness campaign in Spain spotlights the 'invisible' caregivers

3 years ago

J&J nabs label expansion for Stelara in pediatric psoriatic arthritis

3 years ago

Space, the final frontier for drug manufacturing?

3 years ago

AbbVie's Allergan inks $2.3B+ opioid settlement with several states

3 years ago

Bausch Health asserts push to 'vigorously' defend Xifaxan patent litigation

3 years ago

Priority review for Gamida's cell therapy; PhIII shuttered at Akari; Immutep drops data on LAG3 study

3 years ago

Cash-strapped biotech flips ex-MedImmune anti-inflammatory drug for $15M cash

3 years ago

Celyad gets the go-ahead to resume CAR-T trial for colorectal cancer as FDA lifts hold

3 years ago

First page Previous page 486 487 488489490 491 492 Next page Last page